BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25431073)

  • 1. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.
    Fraefel C; Marconi P; Epstein AL
    Methods Mol Biol; 2015; 1254():295-316. PubMed ID: 25431073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors.
    Melendez ME; Fraefel C; Epstein AL
    Methods Mol Biol; 2014; 1144():81-98. PubMed ID: 24671678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Herpes Simplex Virus Type 1 (HSV-1)-Based Amplicon Vectors.
    Fraefel C; Epstein AL
    Methods Mol Biol; 2020; 2060():91-109. PubMed ID: 31617174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy.
    Marconi P; Fraefel C; Epstein AL
    Methods Mol Biol; 2015; 1254():269-93. PubMed ID: 25431072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C
    Curr Protoc Neurosci; 2007 Jul; Chapter 4():Unit 4.14. PubMed ID: 18428655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Laimbacher AS; Fraefel C
    Curr Protoc Neurosci; 2012 Jul; Chapter 4():Unit 4.14. PubMed ID: 22752894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C
    Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.12. PubMed ID: 18428323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 1-derived recombinant and amplicon vectors.
    Fraefel C; Marconi P; Epstein AL
    Methods Mol Biol; 2011; 737():303-43. PubMed ID: 21590403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
    Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
    Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseases.
    Marconi P; Manservigi R; Epstein AL
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):169-83. PubMed ID: 20205051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases.
    Jerusalinsky D; Baez MV; Epstein AL
    J Physiol Paris; 2012 Jan; 106(1-2):2-11. PubMed ID: 22108428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
    Pechan PA; Fotaki M; Thompson RL; Dunn R; Chase M; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1996 Oct; 7(16):2003-13. PubMed ID: 8930661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
    Zaupa C; Revol-Guyot V; Epstein AL
    Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
    Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
    Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1.
    Ferrera R; Cuchet D; Zaupa C; Revol-Guyot V; Ovize M; Epstein AL
    J Mol Cell Cardiol; 2005 Jan; 38(1):219-23. PubMed ID: 15623439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
    Logvinoff C; Epstein AL
    Hum Gene Ther; 2001 Jan; 12(2):161-7. PubMed ID: 11177553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons.
    Müller L; Saydam O; Saeki Y; Heid I; Fraefel C
    J Virol Methods; 2005 Jan; 123(1):65-72. PubMed ID: 15582700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.